Cargando…

Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study

BACKGROUND: It is unclear whether insulin resistance (IR) contributes to excess mortality in patients with type 2 diabetes independent of diabetic kidney disease (DKD), which is strongly associated with IR and is a major risk factor for cardiovascular disease (CVD), the main cause of death in these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penno, Giuseppe, Solini, Anna, Orsi, Emanuela, Bonora, Enzo, Fondelli, Cecilia, Trevisan, Roberto, Vedovato, Monica, Cavalot, Franco, Zerbini, Gianpaolo, Lamacchia, Olga, Nicolucci, Antonio, Pugliese, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962330/ https://www.ncbi.nlm.nih.gov/pubmed/33715620 http://dx.doi.org/10.1186/s12916-021-01936-3

Ejemplares similares

Association between On-Treatment Haemoglobin A(1c) and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment
por: Orsi, Emanuela, et al.
Publicado: (2020)

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study
por: Solini, Anna, et al.
Publicado: (2019)

Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study
por: Pugliese, Giuseppe, et al.
Publicado: (2014)

Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
por: Orsi, Emanuela, et al.
Publicado: (2022)

HbA(1c) Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
por: Penno, Giuseppe, et al.
Publicado: (2013)

Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
por: Penno, Giuseppe, et al.
Publicado: (2020)

Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study
por: Orsi, Emanuela, et al.
Publicado: (2021)

Hemoglobin A(1c) variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study
por: Penno, Giuseppe, et al.
Publicado: (2013)

Diverging Association of Reduced Glomerular Filtration Rate and Albuminuria With Coronary and Noncoronary Events in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
por: Solini, Anna, et al.
Publicado: (2012)

Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
por: Orsi, Emanuela, et al.
Publicado: (2022)

Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study
por: Penno, Giuseppe, et al.
Publicado: (2012)

Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
por: Penno, Giuseppe, et al.
Publicado: (2015)

All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease
por: Copetti, Massimiliano, et al.
Publicado: (2021)

Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”
por: Pugliese, Giuseppe, et al.
Publicado: (2019)

Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
por: Pugliese, Giuseppe, et al.
Publicado: (2020)

Supervised Exercise Training Counterbalances the Adverse Effects of Insulin Therapy in Overweight/Obese Subjects With Type 2 Diabetes
por: Balducci, Stefano, et al.
Publicado: (2012)

One size does not fit all glycemic targets for type 2 diabetes
por: Pozzilli, Paolo, et al.
Publicado: (2014)

The TOSCA.IT Trial: A Study Designed to Evaluate the Effect of Pioglitazone Versus Sulfonylureas on Cardiovascular Disease in Type 2 Diabetes
por: Vaccaro, Olga, et al.
Publicado: (2012)

The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2016)

Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study
por: Garofolo, Monia, et al.
Publicado: (2020)

Platelets, diabetes and myocardial ischemia/reperfusion injury
por: Russo, Isabella, et al.
Publicado: (2017)

La pandemia diabete in Italia
por: Bonora, Enzo
Publicado: (2022)

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study
por: Giorda, Carlo Bruno, et al.
Publicado: (2020)

Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141
por: Garofolo, Monia, et al.
Publicado: (2021)

Changing the Treatment Paradigm for Type 2 Diabetes
por: Del Prato, Stefano, et al.
Publicado: (2009)

Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
por: Morieri, Mario Luca, et al.
Publicado: (2022)

Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes
por: Morieri, Mario Luca, et al.
Publicado: (2022)

Multidrug Treatment of Type 2 Diabetes: A challenge for compliance
por: Miccoli, Roberto, et al.
Publicado: (2011)

Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up: Lessons from the San Luigi Gonzaga Diabetes Study
por: Cavalot, Franco, et al.
Publicado: (2011)

Correlates of Calcaneal Quantitative Ultrasound Parameters in Patients with Diabetes: The Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
por: Conti, Francesco, et al.
Publicado: (2017)

Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
por: Franciosi, Monica, et al.
Publicado: (2013)

The Pros and Cons of Diagnosing Diabetes With A1C
por: Bonora, Enzo, et al.
Publicado: (2011)

Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2020)

Effect of High- versus Low-Intensity Supervised Aerobic and Resistance Training on Modifiable Cardiovascular Risk Factors in Type 2 Diabetes; The Italian Diabetes and Exercise Study (IDES)
por: Balducci, Stefano, et al.
Publicado: (2012)

Changes in Physical Fitness Predict Improvements in Modifiable Cardiovascular Risk Factors Independently of Body Weight Loss in Subjects With Type 2 Diabetes Participating in the Italian Diabetes and Exercise Study (IDES)
por: Balducci, Stefano, et al.
Publicado: (2012)

Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
por: Pacilli, Antonio, et al.
Publicado: (2015)

Optimal therapy of type 2 diabetes: a controversial challenge
por: Dardano, Angela, et al.
Publicado: (2014)

A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy
por: Marchetti, Luca, et al.
Publicado: (2016)

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin
por: Russo, Eleonora, et al.
Publicado: (2013)

Cardiovascular protection with sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Does it apply to all patients?
por: Giorgino, Francesco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e2m6rktvd8d8adfa5v4ulh2qev